Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
78.77 USD | -1.12% | -0.63% | -3.24% |
Feb. 14 | H B Fuller Insider Sold Shares Worth $265,064, According to a Recent SEC Filing | MT |
Feb. 12 | Deutsche Bank Adjusts H.B. Fuller Price Target to $92 From $85, Maintains Buy Rating | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The company is in debt and has limited leeway for investment
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.24% | 4.34B | B+ | ||
+18.18% | 1.45B | D | ||
-3.37% | 1.34B | - | - | |
+18.68% | 1.22B | - | - | |
+1.03% | 1.01B | - | - | |
+7.06% | 1B | - | ||
-9.39% | 870M | - | - | |
-19.25% | 813M | - | - | |
-9.21% | 804M | - | ||
-7.98% | 699M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock
- Equities
- Stock H.B. Fuller Company - Nyse
- Ratings H.B. Fuller Company